The Campbell's Company CPB SPX
Company Overview
The Campbell's Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. It operates through Meals & Beverages, and Snacks segments. The Meals & Beverages segment engages in the retail and foodservice businesses in the United States and Canada. This segment provides Campbell's condensed and ready-to-serve soups; Swanson broth and stocks; Pacific Foods broth, soups, and non-dairy beverages; Prego pasta sauces; Pace Mexican sauces; Campbell's gravies, pasta, beans, and dinner sauces; Swanson canned poultry; V8 juices and beverages; Campbell's tomato juice; Rao's pasta sauces, dry pasta, frozen entrées, frozen pizza, and soups; and Michael Angelo's frozen entrées and pasta sauces, as well as snacking products in foodservice in Canada. Its Snacks segment retails Pepperidge Farm cookies, crackers, fresh bakery, and frozen products, that includes Goldfish crackers, Snyder's of Hanover pretzels, Lance sandwich crackers, Cape Cod and Kettle Brand potato chips, Late July snacks, Snack Factory pretzel crisps, and other snacking products. This segment is also involved in the snacking, and meals and beverage retail business in Latin America. It sells its products through retail food chains, mass discounters and merchandisers, club stores, convenience and dollar stores, e-commerce and other retail, commercial, and non-commercial establishments, and independent contractor distributors. The company was formerly known as Campbell Soup Company and changed its name to The Campbell's Company in November 2024. The Campbell's Company was founded in 1869 and is headquartered in Camden, New Jersey.
Why Investors Should Care
Generates a return on equity of 15.4%, reflecting efficient use of shareholder capital.
Trades at a P/E of 10.7, below the sector median of 20.6.
Offers a dividend yield of 7.05%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Aug 2025 Revenue of $10.25B (+6.4% YoY); net profit $602.00M.
- Trailing 12 Months Year-on-year growth — revenue -4.4%, earnings +86.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.5%, profit CAGR -3.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.47% |
| 1 Year: | -4.40% |
Compounded Profit Growth
| 5 Years: | -3.81% |
| 1 Year: | 86.40% |
Stock Price Performance
| 1 Year: | -24.19% |
| 6 Months: | -14.15% |
| 3 Months: | +11.30% |
| 1 Month: | -2.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)50.59 · Neutral
P/E of 10.73 is below the sector median of 20.61 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 7.05%.
- Generates positive free cash flow.
CONS
- Earnings shrank at -3.8% CAGR over 5 years.
- Trading 31.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CPB The Campbell's Company SPX | 21.89 | 10.73 | $6.53B | 7.05% | 9.37% | 15.39% | 1.47% | -3.81% |
| 2 | WMT Walmart Inc. SPX | 112.53 | 39.62 | $895.52B | 0.89% | 18.21% | 24.13% | 5.27% | 23.30% |
| 3 | COST Costco Wholesale Corporation NDXSPX | 916.54 | 46.24 | $406.47B | 0.63% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPX | 82.45 | 25.93 | $354.74B | 2.52% | 16.47% | 43.37% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPX | 148.05 | 21.64 | $344.75B | 2.92% | 22.93% | 31.11% | 0.36% | 1.66% |
| 6 | PM Philip Morris International Inc. SPX | 180.88 | 25.44 | $281.91B | 3.34% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPX | 135.40 | 17.75 | $184.96B | 4.37% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | MO Altria Group, Inc. SPX | 70.52 | 14.72 | $117.76B | 6.04% | 38.27% | - | 1.24% | -1.89% |
| 9 | MNST Monster Beverage Corporation NDXSPX | 97.57 | 47.14 | $95.42B | 0.00% | 28.33% | 26.65% | 13.03% | 14.82% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | May 2015 | Aug 2015 | Nov 2015 | Jan 2016 | May 2016 | Jul 2016 | Oct 2016 | Jan 2017 | Apr 2017 | Jul 2017 | Oct 2017 | Jan 2018 | Apr 2018 | Jul 2018 | Oct 2018 | Jan 2019 | Apr 2019 | Jul 2019 | Oct 2019 | Jan 2020 | Apr 2020 | Aug 2020 | Nov 2020 | Jan 2021 | May 2021 | Oct 2021 | Jan 2022 | May 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Oct 2024 | Jan 2025 | Apr 2025 | Nov 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 1.64B | 1.61B | 1.62B | 1.75B | 2.20B | 2.17B | 1.95B | 1.78B | 2.18B | 2.16B | 2.24B | 2.11B | 2.34B | 2.28B | 1.98B | 2.24B | 2.21B | 2.13B | 2.58B | 2.48B | 2.23B | 2.52B | 2.46B | 2.37B | 2.77B | 2.69B | 2.48B | 2.68B | 2.56B | 2.37B |
| Gross Profit | 682.00M | 562.00M | 755.00M | 819.00M | 660.00M | 546.00M | 851.00M | 811.00M | 665.00M | 598.00M | 656.00M | 637.00M | 533.00M | 548.00M | 726.00M | 706.00M | 655.00M | 606.00M | 738.00M | 742.00M | 772.00M | 747.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 285.00M | - | 315.00M | 414.00M | 268.00M | - | 457.00M | 205.00M | 298.00M | - | 412.00M | 243.00M | 158.00M | - | 326.00M | 325.00M | 245.00M | - | 317.00M | 350.00M | 273.00M | - | 461.00M | 401.00M | 272.00M | 376.00M | 323.00M | 294.00M | 436.00M | 350.00M | 254.00M | 358.00M | 317.00M | 248.00M | 367.00M | 327.00M | 161.00M | 336.00M | 273.00M | 239.00M |
| Net Income | 179.00M | 17.00M | 194.00M | 265.00M | 185.00M | -81.00M | 292.00M | 101.00M | 176.00M | 318.00M | 275.00M | 285.00M | -393.00M | 94.00M | 194.00M | -59.00M | 84.00M | -8.00M | 166.00M | 1.21B | 168.00M | 86.00M | 309.00M | 245.00M | 160.00M | 261.00M | 212.00M | 188.00M | 297.00M | 232.00M | 160.00M | 234.00M | 203.00M | 133.00M | 218.00M | 173.00M | 66.00M | 194.00M | 145.00M | 124.00M |
| Diluted EPS | 0.57 | 0.05 | 0.62 | 0.85 | 0.59 | -0.26 | 0.94 | 0.33 | 0.58 | 1.04 | 0.91 | 0.95 | -1.31 | 0.31 | 0.64 | -0.20 | 0.28 | -0.03 | 0.55 | 3.97 | 0.55 | 0.28 | 1.02 | 0.80 | 0.52 | 0.86 | 0.70 | 0.62 | 0.99 | 0.77 | 0.53 | 0.78 | 0.68 | 0.44 | 0.72 | 0.58 | 0.22 | 0.65 | 0.48 | 0.41 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Aug 2008 | Aug 2009 | Aug 2010 | Jul 2011 | Jul 2012 | Jul 2013 | Aug 2014 | Aug 2015 | Jul 2016 | Jul 2017 | Jul 2018 | Jul 2019 | Aug 2020 | Aug 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.00B | 7.59B | 7.68B | 7.14B | 7.17B | 8.05B | 8.27B | 8.08B | 7.96B | 5.84B | 6.62B | 8.11B | 8.69B | 8.48B | 8.56B | 9.36B | 9.64B | 10.25B |
| Operating Income | 1.10B | 1.19B | 1.35B | 1.21B | 1.16B | 1.08B | 1.27B | 1.05B | 960.00M | 1.43B | 1.01B | 979.00M | 1.11B | 1.54B | 1.16B | 1.31B | 1.00B | 1.12B |
| Net Income | 1.17B | 736.00M | 844.00M | 805.00M | 774.00M | 458.00M | 866.00M | 666.00M | 563.00M | 887.00M | 261.00M | 211.00M | 1.63B | 1.00B | 757.00M | 858.00M | 567.00M | 602.00M |
| Diluted EPS | 3.03 | 2.05 | 2.42 | 2.42 | 2.41 | 1.44 | 2.74 | 2.13 | 1.81 | 2.89 | 0.86 | 0.70 | 5.36 | 3.29 | 2.51 | 2.85 | 1.89 | 2.01 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jul 2007 | Aug 2008 | Aug 2009 | Aug 2010 | Jul 2011 | Apr 2012 | Jul 2012 | Apr 2013 | Jul 2013 | Aug 2014 | Aug 2015 | Jul 2016 | Jul 2017 | Jul 2018 | Jul 2019 | Aug 2020 | Aug 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 6.06B | 6.28B | 6.86B | - | 6.53B | - | 8.32B | 8.11B | 8.08B | 7.84B | 7.73B | 14.53B | 13.15B | 12.37B | 11.73B | 11.89B | 12.06B | 15.23B | 14.90B |
| Total Equity | 1.30B | 1.32B | 728.00M | 926.00M | 1.09B | - | 898.00M | - | 1.22B | 1.61B | 1.38B | 1.52B | 1.64B | 1.36B | 1.10B | 2.56B | 3.15B | 3.33B | 3.66B | 3.79B | 3.90B |
| Cash & Equivalents | 71.00M | 81.00M | 51.00M | 254.00M | 484.00M | 484.00M | 335.00M | 335.00M | 333.00M | 232.00M | 253.00M | 66.00M | 37.00M | 49.00M | 31.00M | 859.00M | 69.00M | 109.00M | 189.00M | 108.00M | 132.00M |
| Long Term Debt | - | - | 2.25B | 1.95B | 2.43B | - | 2.00B | - | 2.54B | 2.24B | 2.54B | 2.75B | 2.50B | 8.60B | - | - | - | - | - | - | - |
| Total Liabilities | - | - | 5.33B | 5.35B | 5.77B | - | 5.63B | - | 7.11B | 6.51B | 6.70B | 6.30B | 6.08B | 13.16B | 12.04B | 9.80B | 8.58B | 8.56B | 8.39B | 11.44B | 10.99B |
| Current Liabilities | - | - | 1.63B | 2.06B | 1.99B | - | 2.07B | - | 3.28B | 2.99B | 2.81B | 2.56B | 2.40B | 3.59B | 3.38B | 3.08B | 1.81B | 2.89B | 2.22B | 3.58B | 2.91B |
Cash Flows (Annual)
Figures in USD.
| Metric | Aug 2008 | Aug 2009 | Aug 2010 | Jul 2011 | Jul 2012 | Jul 2013 | Aug 2014 | Aug 2015 | Jul 2016 | Jul 2017 | Jul 2018 | Jul 2019 | Aug 2020 | Aug 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 766.00M | 1.17B | 1.06B | 1.14B | 1.12B | 1.02B | 899.00M | 1.21B | 1.49B | 1.29B | 1.30B | 1.40B | 1.40B | 1.03B | 1.18B | 1.14B | 1.19B | 1.13B |
| Investing Cash Flow | 531.00M | -378.00M | -300.00M | -261.00M | -323.00M | -2.15B | -134.00M | -603.00M | -354.00M | -368.00M | -7.20B | 153.00M | 2.27B | -158.00M | -230.00M | -340.00M | -3.13B | -187.00M |
| Financing Cash Flow | -1.30B | -814.00M | -556.00M | -700.00M | -920.00M | 1.24B | -925.00M | -550.00M | -1.10B | -908.00M | 5.81B | -1.59B | -2.99B | -1.67B | -910.00M | -723.00M | 1.86B | -919.00M |
| Capital Expenditure | -298.00M | -345.00M | -315.00M | -272.00M | -323.00M | -336.00M | -347.00M | -380.00M | -341.00M | -338.00M | -407.00M | -384.00M | -299.00M | -275.00M | -242.00M | -370.00M | -517.00M | -426.00M |
| Free Cash Flow | 468.00M | 821.00M | 742.00M | 870.00M | 797.00M | 683.00M | 552.00M | 826.00M | 1.15B | 950.00M | 898.00M | 1.01B | 1.10B | 760.00M | 939.00M | 773.00M | 668.00M | 705.00M |
| Share Buybacks | 903.00M | 527.00M | 472.00M | 728.00M | 412.00M | 153.00M | 76.00M | 244.00M | 143.00M | 437.00M | 86.00M | 0 | 0 | 36.00M | 167.00M | 142.00M | 67.00M | 62.00M |
Ratios (Annual)
Figures in %.
| Metric | Aug 2008 | Aug 2009 | Aug 2010 | Jul 2011 | Jul 2012 | Jul 2013 | Aug 2014 | Aug 2015 | Jul 2016 | Jul 2017 | Jul 2018 | Jul 2019 | Aug 2020 | Aug 2021 | Jul 2022 | Jul 2023 | Jul 2024 | Aug 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 13.7% | 15.6% | 17.6% | 17.0% | 16.1% | 13.4% | 15.3% | 13.0% | 12.1% | 24.5% | 15.3% | 12.1% | 12.7% | 18.2% | 13.6% | 14.0% | 10.4% | 11.0% |
| Net Margin % | 14.6% | 9.7% | 11.0% | 11.3% | 10.8% | 5.7% | 10.5% | 8.2% | 7.1% | 15.2% | 3.9% | 2.6% | 18.7% | 11.8% | 8.8% | 9.2% | 5.9% | 5.9% |
| ROE % | 88.2% | 101.1% | 91.1% | 74.0% | 86.2% | 37.6% | 53.6% | 48.2% | 36.9% | 54.2% | 19.1% | 19.1% | 63.5% | 31.8% | 22.7% | 23.4% | 14.9% | 15.4% |
| ROCE % | - | 26.8% | 32.0% | 24.9% | 25.9% | 21.4% | 24.7% | 20.0% | 18.2% | 26.8% | 9.2% | 10.0% | 11.9% | 15.6% | 12.9% | 13.3% | 8.6% | 9.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 5.73% | 17.11M | $378.19M |
| 2 | Invesco Ltd. | 4.52% | 13.50M | $298.27M |
| 3 | Vanguard Capital Management LLC | 4.41% | 13.16M | $290.85M |
| 4 | State Street Corporation | 4.19% | 12.51M | $276.47M |
| 5 | Dimensional Fund Advisors LP | 3.43% | 10.24M | $226.29M |
| 6 | Vanguard Portfolio Management LLC | 3.35% | 10.01M | $221.16M |
| 7 | Two Sigma Investments, LP | 2.66% | 7.95M | $175.73M |
| 8 | Morgan Stanley | 2.15% | 6.42M | $141.81M |
| 9 | Geode Capital Management, LLC | 1.99% | 5.93M | $131.02M |
| 10 | UBS Group AG | 1.91% | 5.70M | $125.95M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CPB
3 Reasons to Sell CPB and 1 Stock to Buy Instead - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNUUVCUXBRZUNueVNNenB1bmlaNjZUQ1pWTkdCZmpvU3RiVW52YTFBVS1WVlNoUVc3TUJXbjBtUWFNN1ZfMGh2Skwxd1pudk1uckJfVUtvbksyUEJrdEJzTmNDQzBBcWRuVk5pN0sxVy1Kbl9fdGZRbDlWa2swWFF1ZVZjNFQ1ajdHSlpiRT…
The Campbell's Company - Sell: Structural Problems Are Serious - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOUFU1Rzg4WkhHTXRoXzgzWmQySkxnOG55SElaNnNITkRmQ3Y4V0VxTHZaaS1GOEhyNEx6VkhZWjBtUWtqcGQtR1NRdHlkYmdfbWhiVGQ2X0k3SlZYaE16MEoyZl93R2dOcWROMmxHREgwWG9aVmlETTBRM0cyOXFyRkZxRUpLVGxVMzhDTU…
Wide-Moat Campbell's Prudently Pursues Efficiencies To Enable Brand Spending - Morningstar
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPcktpYkpDdnh1ZXlqc09MaHE4QkxvY0JXQVJlYy0yMUdrYVpVa1RYbkp2SDdzVkZCaXV2RVk3cDBqRGpmcHZ4SG13cHVDa0Y5QVNITmhiaTUxMVp1b1ZDa3pxRGFDX2x2bEgyUWxtUFptSG5QWi1ES210N3lkSWxETVp6dEhoVGZDUlIwUm…
1 Oversold Stock Set for a Comeback and 2 We Avoid - StockStory
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNdEY0ODhieVJpME1PUDN0NzBHa2NQV210MjB1X0dsak5EbFRBSmN0SFdyNlk5N3MwdmgzbVJvS0ZIQ1pTNTV1X1J1R3dIOEMyT0M4QnZJVnZUc1BxUlUzUzdKOG1yZEE1bTJBNmNsSzNqUENJUWxkQlprYUhsVmVEQXQ4ZV9IbEZzRHZ0QU…
Campbell's (CPB) Stock Still Looks Undervalued As Shares Fell 41% - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxObFgzQkotbV9tNHNjSzMza0RGVkdETUMwUm54dFNzbzVET2J1ZTJkOGpzclo4MTJDQVRBcXNaY0IwdHBETG50ZzlvUlZhQWo4RmltcThTQ3VGNWhmR3F5Q0JkSFphaWR1ck1ZYzl0bnNMVVFoX1hZTk9zaXFpT3lnNlZpLXRvZlJ3X3dBZ3…
Michael Burry Loads Up On HCA Despite 23% YTD Fall — Calls Hospital Operator An ‘Insanely Efficient Compounder' - Stocktwits
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNdi1NelFYTGMxbEtzejZ2cV9nQ2FNamYyZ2VBTGgwdzlkUndXSGlhVUpwRGxkcHphWWVRU2IweTMyRDlRUWFMc3ViVUZPTEt1OTdXOGxlbEEySmpyQy00NEhGNkJweUpCNEJFTlo2RmRZanctTjFndE9aRzd0MlhxT3FDa1l3ZGEzQUJJUF…
CPB — Frequently Asked Questions
What is the current share price of The Campbell's Company (CPB)?
As of 2026-07-15 16:51 PDT, The Campbell's Company (CPB) trades at $21.89 on NasdaqGS. Its 52-week range is $19.67 to $32.00.
What is the market capitalisation of CPB?
The Campbell's Company (CPB) has a market capitalisation of $6.53B on NasdaqGS.
What is the P/E ratio of CPB?
CPB trades at a trailing price-to-earnings (P/E) ratio of 10.73. The industry average P/E is 20.61. Its price-to-book (P/B) ratio is 1.63.
Does CPB pay a dividend?
The Campbell's Company (CPB) currently offers a dividend yield of 7.05%.
What is the return on equity (ROE) of CPB?
CPB has a return on equity (ROE) of 15.39%. Its return on capital employed (ROCE) is 9.37%.
Is CPB a good stock to buy?
This page provides a data-driven analysis of The Campbell's Company (CPB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.